Jerusalem, June 2, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) today announced U.S. Food and Drug Administration (FDA) approval and commercial launch of its generic version of Galderma's ...

MELVILLE, N.Y. The Food and Drug Administration has approved a topical drug for acne made by E. Fougera, the generic drug maker said Tuesday. The FDA approved Fougera’s adapalene cream in the 0.1% ...

The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in ...

Adapalene 0.3%; alcohol-free. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of cellular differentiation, keratinization, and inflammatory processes.

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced U.S. Food and Drug Administration (FDA) approval and commercial launch of its generic version of ...